Journal ArticleJACC Heart Fail · November 17, 2025
BACKGROUND: Limited data are available on the relationship between body mass index (BMI) and heart failure (HF) physiology or clinical outcomes in patients with heart failure with preserved ejection fraction (HFpEF). OBJECTIVES: This study aims to assess t ...
Full textLink to itemCite
Journal ArticleJ Card Fail · November 2025
BACKGROUND: The clinical significance of at least moderate tricuspid regurgitation (TR) during evaluation for unexplained dyspnea is unclear. This study describes the characteristics, exercise hemodynamics, and 5-year outcomes among patients with moderate ...
Full textLink to itemCite
Journal ArticleHeart Fail Rev · September 2025
Guideline-directed medical therapy is the backbone of heart failure treatment. However, patients continue to experience heart failure symptoms, impaired quality of life, and reduced functional status despite guideline-directed medical and device treatment. ...
Full textLink to itemCite
Journal ArticleCurr Heart Fail Rep · March 19, 2025
PURPOSE OF REVIEW: Cardiovascular effects of obesity may be driven, in part, by the distribution of fat. More recently, epicardial adipose tissue (EAT) has gained recognition as an adverse visceral fat impacting cardiac dysfunction in heart failure with pr ...
Full textOpen AccessLink to itemCite
Journal ArticleAm Heart J · March 2025
BACKGROUND: Despite strong evidence and Class I recommendations to support the use of guideline-directed medical therapy (GDMT) for patients with heart failure with reduced ejection fraction (HFrEF), use of these medications remain suboptimal. There is a g ...
Full textLink to itemCite
Journal ArticleJ Card Fail · January 2025
The baroreflex system is involved in modulating several physiological functions of the cardiovascular system and can modulate cardiac output, blood pressure, and cardiac electrophysiology directly and indirectly. In addition, it is involved in regulating n ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · November 2024
BACKGROUND: Optimal medical therapy (OMT) scoring may stratify clinical risk in real-world chronic heart failure with reduced ejection fraction (HFrEF) by integrating use and dosing of guideline-directed medical therapy (GDMT) for HFrEF. OBJECTIVES: The pu ...
Full textLink to itemCite
Journal ArticleJACC Case Rep · August 7, 2024
Patients with HeartMate 3 left ventricular assist devices may develop aortic root thrombus, yet its prevalence and associated risks are unknown. We present 2 patients who developed aortic root thromboembolism and acute coronary occlusions. We additionally ...
Full textLink to itemCite
Journal ArticleJACC Adv · August 2024
BACKGROUND: The cardiopulmonary exercise test (CPET) is considered a gold standard in assessing cardiorespiratory fitness (CRF) but has limited accessibility due to competency requirements and cost. Incorporating portable sensor devices into a simple bedsi ...
Full textOpen AccessLink to itemCite
Journal ArticleAm Heart J · May 2024
AIMS: Type 2 diabetes (T2D) is a risk factor for cardiovascular and non-cardiovascular mortality. However, global distribution of cause-specific deaths in T2D is poorly understood. We characterized cause-specific deaths by geographic region among individua ...
Full textLink to itemCite
Journal ArticleJ Card Fail · February 2024
Despite recent advances in the use of guideline-directed medical therapy (GDMT) for patients with heart failure with reduced ejection fraction (HFrEF), achievement of target GDMT use and up-titration to goal dosages continue to be modest. In recent years, ...
Full textOpen AccessLink to itemCite
Journal ArticleN Engl J Med · September 14, 2023
BACKGROUND: Ferric carboxymaltose therapy reduces symptoms and improves quality of life in patients who have heart failure with a reduced ejection fraction and iron deficiency. Additional evidence about the effects of ferric carboxymaltose on clinical even ...
Full textLink to itemCite
ConferenceAm Heart J · September 2023
BACKGROUND: Electronic health record (EHR)-based identification of heart failure with preserved ejection fraction (HFpEF) in the clinical setting may facilitate screening for clinical trials by improving the understanding of its epidemiology and outcomes; ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Transl Res · June 2023
Studies have shown poor correlation between intra-cardiac pressures and blood volume (BV) measurements including HF. The impact of sex and left ventricular ejection fraction (LVEF) on this relationship has not been studied. We obtained pressure (pulmonary ...
Full textLink to itemCite
Journal ArticleEur Heart J · June 1, 2023
AIMS: Severe tricuspid regurgitation (TR) exhibits high 1-year morbidity and mortality, yet long-term cardiovascular risk overall and by subgroups remains unknown. This study characterizes 5-year outcomes and identifies distinct clinical risk profiles of s ...
Full textLink to itemCite
Journal ArticleJ Card Fail · March 2023
Vericiguat is a soluble guanylate cyclase stimulator approved by multiple global regulatory bodies and recommended in recently updated clinical practice guidelines to reduce morbidity and mortality in patients with worsening chronic heart failure (HF) with ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · February 2023
BACKGROUND: Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) improves clinical outcomes and quality of life. Optimizing GDMT in the hospital is associated with greater long-term use in HFrEF. This study aim ...
Full textLink to itemCite
Journal ArticleAm Heart J · December 2022
BACKGROUND: Heart Failure with Preserved Ejection Fraction (HFpEF) is a heterogenous disease with few therapies proven to provide clinical benefit. Machine learning can characterize distinct phenotypes and compare outcomes among patients with HFpEF who are ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · November 2022
BACKGROUND: Neighborhood socioeconomic status (SES) is associated with worse health outcomes, yet its relationship with in-hospital heart failure (HF) outcomes and quality metrics are underexplored. We examined the association between socioeconomic neighbo ...
Full textLink to itemCite
Journal ArticleJ Card Fail · October 2022
BACKGROUND: It is unknown whether digital applications can improve guideline-directed medical therapy (GDMT) and outcomes in heart failure with reduced ejection fraction (HFrEF). METHODS AND RESULTS: Care Optimization Through Patient and Hospital Engagemen ...
Full textLink to itemCite
Journal ArticleJ Card Fail · September 2022
BACKGROUND: The role of blood volume (BV) expansion vs a change in vascular compliance in worsening heart failure (HF) remains under debate. We aimed to assess the relationship between BV and resting and stress hemodynamics in worsening HF and to further e ...
Full textLink to itemCite
Journal ArticleJ Card Fail · June 2022
BACKGROUND: Worsening heart failure (HF) often requires hospitalization but in some cases may be managed in the outpatient or emergency department (ED) settings. The predictors and clinical significance of ED visits without admission vs hospitalization are ...
Full textLink to itemCite
Journal ArticleJ Card Fail · January 2022
BACKGROUND: Pericardial adipose tissue (PAT) is associated with adverse cardiovascular outcomes in those with and without established heart failure (HF). However, it is not known whether PAT is associated with adverse outcomes in patients with end-stage HF ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · November 16, 2021
Background Nonalcoholic fatty liver disease (NAFLD) and heart failure (HF) are increasing in prevalence. The independent association between NAFLD and downstream risk of HF and HF subtypes (HF with preserved ejection fraction and HF with reduced ejection f ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · November 16, 2021
Sodium-glucose cotransporter-2 inhibitor therapy is well suited for initiation during the heart failure hospitalization, owing to clinical benefits that accrue rapidly within days to weeks, a strong safety and tolerability profile, minimal to no effects on ...
Full textLink to itemCite
Journal ArticleJACC Basic Transl Sci · November 2021
Although there is an established bidirectional relationship between heart failure with reduced ejection fraction and liver disease, the association between heart failure with preserved ejection fraction (HFpEF) and liver diseases, such as nonalcoholic fatt ...
Full textLink to itemCite
Journal ArticleJ Card Fail · September 2021
BACKGROUND: Hepatocyte growth factor (HGF) is a cytokine and marker of cardiovascular disease (CVD) risk. Less is known about HGF and incident heart failure (HF). We examined the association of HGF with incident HF and its subtypes in a multiethnic cohort. ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · July 20, 2021
Background Visceral adipose tissue (VAT) is associated with incident heart failure (HF) and HF with preserved ejection fraction, yet it is unknown how pericardial and abdominal adiposity affect HF and mortality risks in Black individuals. We examined the a ...
Full textLink to itemCite
Journal ArticleClin Cardiol · May 2021
BACKGROUND: Cardiovascular disease (CVD) hospitalizations declined worldwide during the COVID-19 pandemic. It is unclear how shelter-in-place orders affected acute CVD hospitalizations, illness severity, and outcomes. HYPOTHESIS: COVID-19 pandemic was asso ...
Full textLink to itemCite
Journal ArticleEur J Heart Fail · September 2020
The role of obesity in the pathogenesis of heart failure (HF), and in particular HF with preserved ejection fraction (HFpEF), has drawn significant attention in recent years. The prevalence of both obesity and HFpEF has increased worldwide over the past de ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · August 2020
BACKGROUND: GlycA, a nuclear magnetic resonance composite marker of systemic inflammation, reflects serum concentration and glycosylation state of main acute phase reactants. Prior studies have shown plasma GlycA levels were associated with cardiovascular ...
Full textLink to itemCite
Journal ArticleJACC Case Rep · March 2020
A 77-year-old man with history of ischemic cardiomyopathy and left ventricular assist device (LVAD) presented with abdominal pain after a lawn mower accident. Examination and imaging revealed a displaced LVAD driveline and a pericardial hematoma secondary ...
Full textOpen AccessLink to itemCite
Journal ArticleJACC CardioOncol · December 2019
Transthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of heart failure. Fortunately, the disease now has an approved therapy, with many others under development. Assessment of prognosis in ATTR-CM is critical to ...
Full textOpen AccessLink to itemCite
Journal ArticleJACC Heart Fail · December 2018
OBJECTIVES: This study sought to compare various measures of adiposity with risk for incident hospitalized heart failure (HF) with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF). BACKGROUND: Obesity is a risk factor for HF, parti ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · November 20, 2018
Background Obesity contributes significantly to risk of atherosclerotic cardiovascular disease (ASCVD) and especially for heart failure (HF). An elevated body mass index (BMI) in older adults might not carry the same risk as in younger adults, but measured ...
Full textLink to itemCite
Journal ArticleRetina · December 2016
PURPOSE: Failure of blood pressure (BP) to dip during sleep (nondipper pattern) is associated with cardiovascular disease and stroke. The prevalence and degree of nondipping and masked hypertension in patients with retinal vein occlusion (RVO), which is as ...
Full textLink to itemCite
Journal ArticleJ Clin Hypertens (Greenwich) · January 2015
Home blood pressure monitoring (HBPM) readings predict the increased risks of cardiovascular events and end-organ damage independent of office blood pressure (BP). Numeracy (the ability to handle numbers) may limit the feasibility of patients' performing H ...
Full textLink to itemCite